154 related articles for article (PubMed ID: 37714365)
1. Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy.
Fadaie M; Dianat-Moghadam H; Ghafouri E; Naderi S; Darvishali MH; Ghovvati M; Khanahmad H; Boshtam M; Makvandi P
Environ Res; 2023 Dec; 238(Pt 1):117132. PubMed ID: 37714365
[TBL] [Abstract][Full Text] [Related]
2. M13 phage: a versatile building block for a highly specific analysis platform.
Wang R; Li HD; Cao Y; Wang ZY; Yang T; Wang JH
Anal Bioanal Chem; 2023 Jul; 415(18):3927-3944. PubMed ID: 36867197
[TBL] [Abstract][Full Text] [Related]
3. Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy.
Chang C; Guo W; Yu X; Guo C; Zhou N; Guo X; Huang RL; Li Q; Zhu Y
Mater Today Bio; 2023 Jun; 20():100612. PubMed ID: 37063776
[TBL] [Abstract][Full Text] [Related]
4. Immunological properties of the SLLTEVET epitope of Influenza A virus in multiple display on filamentous M13 phage.
Lotfi Z; Golchin M; Khalili-Yazdi A; Khalili M
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():76-80. PubMed ID: 31300131
[TBL] [Abstract][Full Text] [Related]
5. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
[TBL] [Abstract][Full Text] [Related]
6. Efficient affinity-tagging of M13 phage capsid protein IX for immobilization of protein III-displayed oligopeptide probes on abiotic platforms.
Tong Z; Silo-Suh LA; Kalalah A; Dawson P; Chin BA; Suh SJ
Appl Microbiol Biotechnol; 2020 Feb; 104(3):1201-1209. PubMed ID: 31900564
[TBL] [Abstract][Full Text] [Related]
7. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.
Kim A; Shin TH; Shin SM; Pham CD; Choi DK; Kwon MH; Kim YS
PLoS One; 2012; 7(12):e51813. PubMed ID: 23251631
[TBL] [Abstract][Full Text] [Related]
8. [Advances of development of phage display systems].
Meng FM; Zhang CH; Ai YC
Yi Chuan; 2011 Oct; 33(10):1113-20. PubMed ID: 21993286
[TBL] [Abstract][Full Text] [Related]
9. Biofilm Control in Flow-Through Systems Using Polyvalent Phages Delivered by Peptide-Modified M13 Coliphages with Enhanced Polysaccharide Affinity.
Sun R; Yu P; Zuo P; Villagrán D; Mathieu J; Alvarez PJJ
Environ Sci Technol; 2022 Dec; 56(23):17177-17187. PubMed ID: 36413403
[TBL] [Abstract][Full Text] [Related]
10. The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine.
Ul Haq I; Krukiewicz K; Yahya G; Haq MU; Maryam S; Mosbah RA; Saber S; Alrouji M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675046
[TBL] [Abstract][Full Text] [Related]
11. Production and Purification of Recombinant Filamentous Bacteriophages Displaying Immunogenic Heterologous Epitopes.
Deng L; Linero F; Saelens X
Methods Mol Biol; 2016; 1404():483-495. PubMed ID: 27076317
[TBL] [Abstract][Full Text] [Related]
12. Plaque reduction test: an alternative method to assess specific antibody response to pIII-displayed peptide of filamentous phage M13.
Yang WJ; Shiuan D
J Immunol Methods; 2003 May; 276(1-2):175-83. PubMed ID: 12738371
[TBL] [Abstract][Full Text] [Related]
13. Citrulline-modified phage display: a novel high-throughput discovery approach for the identification of citrulline-containing ligands.
Somers K; Stinissen P; Somers V
Proteomics; 2011 Jun; 11(12):2550-4. PubMed ID: 21584941
[TBL] [Abstract][Full Text] [Related]
14. Quantification of M13 and T7 bacteriophages by TaqMan and SYBR green qPCR.
Peng X; Nguyen A; Ghosh D
J Virol Methods; 2018 Feb; 252():100-107. PubMed ID: 29196210
[TBL] [Abstract][Full Text] [Related]
15. Engineering of M13 Bacteriophage for Development of Tissue Engineering Materials.
Jin HE; Lee SW
Methods Mol Biol; 2018; 1776():487-502. PubMed ID: 29869262
[TBL] [Abstract][Full Text] [Related]
16. Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy.
Ulfo L; Cantelli A; Petrosino A; Costantini PE; Nigro M; Starinieri F; Turrini E; Zadran SK; Zuccheri G; Saporetti R; Di Giosia M; Danielli A; Calvaresi M
Nanoscale; 2022 Jan; 14(3):632-641. PubMed ID: 34792088
[TBL] [Abstract][Full Text] [Related]
17. Phage-based vaccines.
Bao Q; Li X; Han G; Zhu Y; Mao C; Yang M
Adv Drug Deliv Rev; 2019 May; 145():40-56. PubMed ID: 30594492
[TBL] [Abstract][Full Text] [Related]
18. Genetically modified filamentous phage as bactericidal agents: a pilot study.
Hagens S; Bläsi U
Lett Appl Microbiol; 2003; 37(4):318-23. PubMed ID: 12969496
[TBL] [Abstract][Full Text] [Related]
19. Novel helper phage design: intergenic region affects the assembly of bacteriophages and the size of antibody libraries.
Dueñas M; Borrebaeck CA
FEMS Microbiol Lett; 1995 Jan; 125(2-3):317-21. PubMed ID: 7875580
[TBL] [Abstract][Full Text] [Related]
20. Research Progress of M13 Bacteriophage-Based Biosensors.
Moon JS; Choi EJ; Jeong NN; Sohn JR; Han DW; Oh JW
Nanomaterials (Basel); 2019 Oct; 9(10):. PubMed ID: 31614669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
